4.1 Review

Update in the medical therapy of Cushing's disease

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Potential Role for Retinoic Acid in Patients with Cushing's Disease

Francesca Pecori Giraldi et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Endocrinology & Metabolism

Mifepristone, a Glucocorticoid Receptor Antagonist, Produces Clinical and Metabolic Benefits in Patients with Cushing's Syndrome

Maria Fleseriu et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Medicine, General & Internal

A 12-Month Phase 3 Study of Pasireotide in Cushing's Disease

Annamaria Colao et al.

NEW ENGLAND JOURNAL OF MEDICINE (2012)

Review Endocrinology & Metabolism

Management of Cushing disease

Nicholas A. Tritos et al.

NATURE REVIEWS ENDOCRINOLOGY (2011)

Article Endocrinology & Metabolism

Cabergoline monotherapy in the long-term treatment of Cushing's disease

Ariane Godbout et al.

EUROPEAN JOURNAL OF ENDOCRINOLOGY (2010)

Letter Medicine, General & Internal

Pasireotide Alone or with Cabergoline and Ketoconazole in Cushing's Disease

Richard A. Feelders et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Review Endocrinology & Metabolism

The clinical-molecular interface of somatostatin, dopamine and their receptors in pituitary pathophysiology

Diego Ferone et al.

JOURNAL OF MOLECULAR ENDOCRINOLOGY (2009)

Article Endocrinology & Metabolism

Retinoic acid as a novel medical therapy for Cushing's disease in dogs

Victor Castillo et al.

ENDOCRINOLOGY (2006)

Article Endocrinology & Metabolism

Dopamine receptor expression and function in corticotroph pituitary tumors

R Pivonello et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)

Article Medicine, Research & Experimental

Retinoic acid prevents experimental Cushing syndrome

M Páez-Pereda et al.

JOURNAL OF CLINICAL INVESTIGATION (2001)